The real sleeper story is the NIH's quiet redefinition of "clinical trials" — by removing registration requirements for basic human experiments, a massive category of human research just went dark from public databases at the exact moment political pressure is being applied to what gets studied and what doesn't.
The simultaneous collapse of WHO coordination, CDC transparency rollbacks, and NIH database exemptions create a global blind spot that mirrors the same information vacuum that allowed COVID-19 to spread unchecked in early 2020 — and this time, biotech and AI are accelerating the pace at which novel therapies (and novel threats) can emerge faster than any oversight body can track.